EE200300587A - Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine - Google Patents

Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Info

Publication number: EE200300587A
Authority: EE; Estonia
Prior art keywords: preparation; pharmaceutical composition; liquid pharmaceutical; liquid; composition
Prior art date: 2001-05-25

Application number

EEP200300587A

Other languages

English (en)

Inventor

Mahesh Kulkarni Neema

Schneider Michael

Bernard Silbering Steven

Richard Meyer-Wonnay Hans

Sanii-Yahyai Nahid

Original Assignee

Warner-Lambert Company Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2002-04-29

Publication date

2004-02-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26968180&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200300587(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-29 Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc

2004-02-16 Publication of EE200300587A publication Critical patent/EE200300587A/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

EEP200300587A 2001-05-25 2002-04-29 Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine EE200300587A (et)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US29383201P	2001-05-25	2001-05-25
US34373301P	2001-10-25	2001-10-25
PCT/IB2002/001500 WO2002094220A1 (en)	2001-05-25	2002-04-29	Liquid pharmaceutical composition

Publications (1)

Publication Number	Publication Date
EE200300587A true EE200300587A (et)	2004-02-16

Family

ID=26968180

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300587A EE200300587A (et)	2001-05-25	2002-04-29	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine

Country Status (44)

Country	Link
US (2)	US20020198261A1 (et)
EP (1)	EP1395242B1 (et)
JP (1)	JP2004534764A (et)
KR (1)	KR100582963B1 (et)
CN (1)	CN100346779C (et)
AP (1)	AP1815A (et)
AR (1)	AR033922A1 (et)
AT (1)	ATE334656T1 (et)
AU (1)	AU2002258026B2 (et)
BG (1)	BG108376A (et)
BR (1)	BR0209973A (et)
CA (1)	CA2446574C (et)
CR (1)	CR7150A (et)
CY (1)	CY1105147T1 (et)
CZ (1)	CZ299755B6 (et)
DE (1)	DE60213592T2 (et)
DK (1)	DK1395242T3 (et)
DO (1)	DOP2002000403A (et)
EA (1)	EA008087B1 (et)
EE (1)	EE200300587A (et)
EG (1)	EG24078A (et)
ES (1)	ES2265040T3 (et)
GE (1)	GEP20053620B (et)
HK (1)	HK1062646A1 (et)
HR (1)	HRP20030833B1 (et)
HU (1)	HUP0401366A2 (et)
IL (1)	IL158359A0 (et)
IS (1)	IS2428B (et)
MA (1)	MA27026A1 (et)
MX (1)	MXPA03009392A (et)
MY (1)	MY128615A (et)
NO (1)	NO20035200L (et)
NZ (1)	NZ529173A (et)
OA (1)	OA12604A (et)
PA (1)	PA8545901A1 (et)
PE (1)	PE20030087A1 (et)
PL (1)	PL366384A1 (et)
PT (1)	PT1395242E (et)
RS (1)	RS87203A (et)
SI (1)	SI1395242T1 (et)
SK (1)	SK286227B6 (et)
SV (1)	SV2003001053A (et)
WO (1)	WO2002094220A1 (et)
ZA (1)	ZA200308393B (et)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0934061T6 (en)	1996-07-24	2015-01-26	Warner Lambert Co	Isobutylgaba and its derivatives for the treatment of pain
US8048917B2 (en)	2005-04-06	2011-11-01	Xenoport, Inc.	Prodrugs of GABA analogs, compositions and uses thereof
BR0313432A (pt) *	2002-08-15	2005-07-12	Pfizer	Uso terapêutico de aminoácidos bicìclicos ou tricìclicos fundidos
EP1572188A1 (en) *	2002-12-13	2005-09-14	Warner-Lambert Company LLC	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
CA2451267A1 (en) *	2002-12-13	2004-06-13	Warner-Lambert Company Llc	Pharmaceutical uses for alpha2delta ligands
JP2006511624A (ja) *	2002-12-20	2006-04-06	ダイノジェンファーマシューティカルズ，インコーポレイテッド	α２δサブユニット・カルシウム・チャンネル調節因子を使用する無痛性膀胱障害を処置するための方法
US7169812B2 (en) *	2003-07-01	2007-01-30	Medtronic, Inc.	Process for producing injectable gabapentin compositions
ATE449633T1 (de) *	2003-09-12	2009-12-15	Pfizer	Kombinationen aus alpha-2-delta liganden und serotonin / noradrenalin-wiederaufnahmehemmern
CN1867359B (zh) *	2003-10-08	2010-12-15	马林克罗特公司	哌甲酯溶液及其制药用途和制备方法
US20050090548A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of epilepsy
US20050090549A1 (en) *	2003-10-23	2005-04-28	Medtronic, Inc.	Intrathecal gabapentin for treatment of pain
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
DE102004015752B4 (de) *	2004-03-31	2007-04-05	Christian-Albrechts-Universität Zu Kiel	Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen
KR100870381B1 (ko) *	2004-10-14	2008-11-25	다이킨 고교 가부시키가이샤	분위기개변방법, 그리고 이에 이용되는 분무제 및 분무장치
EP1919861A2 (de) *	2005-08-11	2008-05-14	Boehringer Ingelheim International GmbH	Verbindungen zur behandlung der alzheimer erkrankung
WO2007017510A2 (de) *	2005-08-11	2007-02-15	Boehringer Ingelheim International Gmbh	Isophthalsäurediamide zur behandlung der alzheimer erkrankung
DE102007019071A1 (de) *	2007-04-23	2008-10-30	Ratiopharm Gmbh	Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
EP2116618A1 (en) *	2008-05-09	2009-11-11	Agency for Science, Technology And Research	Diagnosis and treatment of Kawasaki disease
EP2246044A1 (en) *	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Paediatric solutions comprising a beta-blocker
HU230031B1 (hu)	2010-03-01	2015-05-28	Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság	Pregabalint és izomaltot tartalmazó stabilizált gyógyszerkészítmény
TR201005241A1 (tr) *	2010-05-25	2012-01-23	Sanovel �La� San. Ve T�C. A.�.	Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
WO2015144825A1 (en) *	2014-03-27	2015-10-01	Sanovel Ilac Sanayi Ve Ticaret A.S.	Oral liquid pharmaceutical solution of gabapentin
CN104940930A (zh) *	2015-05-31	2015-09-30	黑龙江佰彤儿童药物研究有限公司	一种治疗儿童癫痫药物口服乳剂及其制备方法
US11918684B2 (en)	2017-03-13	2024-03-05	Liqmeds Worldwide Limited	Pharmaceutical composition of oral suspension of immunosuppressive agents
WO2019038584A1 (en)	2017-08-19	2019-02-28	Ftf Pharma Private Limited	ORAL PHARMACEUTICAL COMPOSITION COMPRISING ZONISAMIDE AND PREPARATION METHOD THEREOF
WO2019186515A1 (en) *	2018-03-30	2019-10-03	Ftf Pharma Private Limited	Liquid pharmaceutical compositions of antiepileptic drugs
WO2020039264A2 (en) *	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Chemotherapeutic pharmaceutical suspension for oral dosage
WO2020039263A2 (en)	2018-08-18	2020-02-27	Ftf Pharma Private Limited	Pharmaceutical suspension for oral dosage
CN113631150A (zh)	2019-03-26	2021-11-09	奥赖恩公司	普瑞巴林制剂及其用途
WO2022168968A1 (ja) *	2021-02-05	2022-08-11	学校法人近畿大学	末梢神経障害の予防又は改善剤
CA3230309A1 (en) *	2021-08-31	2023-03-09	Jr. Samuel A. Testino	Stable gabapentin powder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
BR9910508B1 (pt) *	1998-05-15	2012-01-24		preparações farmacêuticas estabilizadas de derivados de ácido gama-aminobutìrico.
CA2430298A1 (en) *	2000-11-30	2002-06-06	Banavara Lakshman Mylari	Combination of gaba agonists and sorbitol dehydrogenase inhibitors

2002
- 2002-04-29 AT AT02727834T patent/ATE334656T1/de not_active IP Right Cessation
- 2002-04-29 PT PT02727834T patent/PT1395242E/pt unknown
- 2002-04-29 ES ES02727834T patent/ES2265040T3/es not_active Expired - Lifetime
- 2002-04-29 RS YU87203A patent/RS87203A/sr unknown
- 2002-04-29 CA CA002446574A patent/CA2446574C/en not_active Expired - Fee Related
- 2002-04-29 EP EP02727834A patent/EP1395242B1/en not_active Expired - Lifetime
- 2002-04-29 GE GE5340A patent/GEP20053620B/en unknown
- 2002-04-29 DK DK02727834T patent/DK1395242T3/da active
- 2002-04-29 OA OA1200300296A patent/OA12604A/en unknown
- 2002-04-29 EE EEP200300587A patent/EE200300587A/et unknown
- 2002-04-29 AU AU2002258026A patent/AU2002258026B2/en not_active Ceased
- 2002-04-29 JP JP2002590939A patent/JP2004534764A/ja active Pending
- 2002-04-29 PL PL02366384A patent/PL366384A1/xx not_active Application Discontinuation
- 2002-04-29 BR BR0209973-0A patent/BR0209973A/pt not_active IP Right Cessation
- 2002-04-29 KR KR1020037015326A patent/KR100582963B1/ko not_active IP Right Cessation
- 2002-04-29 CZ CZ20033066A patent/CZ299755B6/cs not_active IP Right Cessation
- 2002-04-29 HU HU0401366A patent/HUP0401366A2/hu unknown
- 2002-04-29 EA EA200301152A patent/EA008087B1/ru not_active IP Right Cessation
- 2002-04-29 SI SI200230371T patent/SI1395242T1/xx unknown
- 2002-04-29 CN CNB028098080A patent/CN100346779C/zh not_active Expired - Fee Related
- 2002-04-29 DE DE60213592T patent/DE60213592T2/de not_active Expired - Fee Related
- 2002-04-29 AP APAP/P/2003/002907A patent/AP1815A/en active
- 2002-04-29 WO PCT/IB2002/001500 patent/WO2002094220A1/en active IP Right Grant
- 2002-04-29 SK SK1411-2003A patent/SK286227B6/sk not_active IP Right Cessation
- 2002-04-29 IL IL15835902A patent/IL158359A0/xx unknown
- 2002-04-29 NZ NZ529173A patent/NZ529173A/en unknown
- 2002-04-29 MX MXPA03009392A patent/MXPA03009392A/es active IP Right Grant
- 2002-05-21 MY MYPI20021869A patent/MY128615A/en unknown
- 2002-05-22 EG EG20020541A patent/EG24078A/xx active
- 2002-05-23 AR ARP020101922A patent/AR033922A1/es unknown
- 2002-05-23 DO DO2002000403A patent/DOP2002000403A/es unknown
- 2002-05-23 PE PE2002000433A patent/PE20030087A1/es not_active Application Discontinuation
- 2002-05-24 PA PA20028545901A patent/PA8545901A1/es unknown
- 2002-05-24 SV SV2002001053A patent/SV2003001053A/es not_active Application Discontinuation
- 2002-05-28 US US10/156,213 patent/US20020198261A1/en not_active Abandoned
2003
- 2003-06-24 US US10/602,215 patent/US7256216B2/en not_active Expired - Lifetime
- 2003-10-09 IS IS6986A patent/IS2428B/is unknown
- 2003-10-14 HR HR20030833A patent/HRP20030833B1/xx not_active IP Right Cessation
- 2003-10-28 ZA ZA2003/08393A patent/ZA200308393B/en unknown
- 2003-11-17 CR CR7150A patent/CR7150A/es not_active Application Discontinuation
- 2003-11-19 MA MA27406A patent/MA27026A1/fr unknown
- 2003-11-21 BG BG108376A patent/BG108376A/bg unknown
- 2003-11-24 NO NO20035200A patent/NO20035200L/no not_active Application Discontinuation
2004
- 2004-07-28 HK HK04105579A patent/HK1062646A1/xx not_active IP Right Cessation
2006
- 2006-08-10 CY CY20061101125T patent/CY1105147T1/el unknown

Also Published As

Publication number	Publication date
SK286227B6 (sk)	2008-05-06
CA2446574C (en)	2008-04-01
US7256216B2 (en)	2007-08-14
CA2446574A1 (en)	2002-11-28
DOP2002000403A (es)	2002-11-30
CZ299755B6 (cs)	2008-11-12
JP2004534764A (ja)	2004-11-18
OA12604A (en)	2006-06-08
HUP0401366A2 (hu)	2004-11-29
SV2003001053A (es)	2003-03-18
HK1062646A1 (en)	2004-11-19
IS6986A (is)	2003-10-09
WO2002094220A1 (en)	2002-11-28
SI1395242T1 (en)	2006-10-31
CR7150A (es)	2004-02-23
MXPA03009392A (es)	2004-01-29
PT1395242E (pt)	2006-11-30
EP1395242B1 (en)	2006-08-02
SK14112003A3 (sk)	2004-08-03
BG108376A (bg)	2005-04-30
GEP20053620B (en)	2005-09-26
NO20035200D0 (no)	2003-11-24
DE60213592D1 (de)	2006-09-14
AU2002258026B2 (en)	2007-08-02
ZA200308393B (en)	2005-04-26
PA8545901A1 (es)	2003-09-05
RS87203A (en)	2006-10-27
PE20030087A1 (es)	2003-02-14
BR0209973A (pt)	2004-04-06
DE60213592T2 (de)	2007-08-09
PL366384A1 (en)	2005-01-24
AR033922A1 (es)	2004-01-07
NZ529173A (en)	2005-07-29
CZ20033066A3 (cs)	2004-08-18
CN1509165A (zh)	2004-06-30
US20020198261A1 (en)	2002-12-26
IL158359A0 (en)	2004-05-12
CY1105147T1 (el)	2010-03-03
MY128615A (en)	2007-02-28
US20040072904A1 (en)	2004-04-15
KR20040003006A (ko)	2004-01-07
CN100346779C (zh)	2007-11-07
IS2428B (is)	2008-10-15
HRP20030833A2 (en)	2004-08-31
NO20035200L (no)	2003-11-24
MA27026A1 (fr)	2004-12-20
EA008087B1 (ru)	2007-02-27
AP2003002907A0 (en)	2003-12-31
ATE334656T1 (de)	2006-08-15
HRP20030833B1 (en)	2007-04-30
EP1395242A1 (en)	2004-03-10
EA200301152A1 (ru)	2004-04-29
AP1815A (en)	2008-01-04
DK1395242T3 (da)	2006-10-30
EG24078A (en)	2008-05-11
ES2265040T3 (es)	2007-02-01
KR100582963B1 (ko)	2006-05-24

Publication	Publication Date	Title
EE200300587A (et)	2004-02-16	Vedel farmatseutiline kompositsioon, selle valmistamise meetod ja kasutamine
EE200300236A (et)	2003-08-15	1,2-difenüülasetidinoonid, nende kasutamine, ravim ja selle valmistamismeetod
EE200300581A (et)	2004-02-16	Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
EE200100684A (et)	2003-04-15	Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE200300369A (et)	2003-10-15	Atsüülitud indanüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200300327A (et)	2003-10-15	Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
EE05214B1 (et)	2009-10-15	Polool-IFN- β konjugaat, selle valmistamismeetod ja farmatseutiline kompositsioon
EE200300171A (et)	2003-06-16	Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
EE05475B1 (et)	2011-10-17	Superantigeeni sisaldav konjugaat, konjugaadi kasutamine ja konjugaati sisaldav farmatseutiline kompositsioon
EE200300370A (et)	2003-10-15	Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat
EE200400028A (et)	2004-04-15	Ravimpreparaat, selle valmistamise meetod ja selle kasutamine meditsiinis
NO20031273L (no)	2003-05-14	Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme
EE200000596A (et)	2002-06-17	Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod
PL394600A1 (pl)	2011-07-18	Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna
IS6378A (is)	2002-05-10	Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
EE200300488A (et)	2003-12-15	Lipiiditaset alandava toimega bifenüülkarboksamiidühend, meetod selle valmistamiseks ning seda sisaldav ravimkompositsioon
EE05175B1 (et)	2009-06-15	Asendatud bensimidasooli preparaat, meetod selle valmistamiseks ja selle kasutamine meditsiinis
EE04902B1 (et)	2007-10-15	Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
HUP0401107A3 (en)	2004-10-28	Novel benzo-fused heterocycles, their use process for their preparation and pharmaceutical compositions containing them
EE05168B1 (et)	2009-06-15	N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
EE200100662A (et)	2003-04-15	Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine
HUP0401369A3 (en)	2006-05-29	Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
EE200100209A (et)	2002-06-17	Tritsüklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE04260B1 (et)	2004-04-15	Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
EE200200637A (et)	2004-04-15	Torasemiidi uudne polümorf V, selle valmistamismeetod, kasutamine ja ravimvorm